Author:
Redd Meredith A.,Scheuer Sarah E.,Saez Natalie J.,Gao Ling,Hicks Mark,Villanueva Jeanette E.,Reichelt Melissa E.,Peart Jason N.,See Hoe Louise E.,Chiu Han S.,Chen Xiaoli,Sun Yuliangzi,Suen Jacky Y.,Hatch Robert J,Rollo Ben,Alzubaidi Mubarak A.H.,Maljevic Snezana,Quaife-Ryan Greg A.,Thomas Walter G.,Hudson James E.,Porrello Enzo R.,Cuellar-Partida Gabriel,Fraser John F.,Petrou Steven,King Glenn F.,Macdonald Peter S.,Palpant Nathan J.
Abstract
AbstractThe proton-gated acid-sensing ion channel 1a (ASIC1a) is implicated in the injury response to cerebral ischemia but little is known about its role in cardiac ischemia. We provide genetic evidence that ASIC1a is involved in myocardial ischemia-reperfusion injury (IRI) and show that pharmacological inhibition of ASIC1a yields robust cardioprotection in rodent and human models of cardiac ischemia, resulting in improved post-IRI cardiac viability and function. Consistent with a key role for ASIC1a in cardiac ischemia, we show that polymorphisms in the ASIC1 genetic locus are strongly associated with myocardial infarction. Collectively, our data provide compelling evidence that ASIC1a is a key target for cardioprotective drugs to reduce the burden of disease associated with myocardial ischemia.
Publisher
Cold Spring Harbor Laboratory
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献